Extracorporeal Membrane Oxygenation
Continuous ultrafiltration with membrane oxygenation can help patients with COVID-19
COVID-19 infection has resulted in AKI in about 3% to 15% of cases in the United States, and severe infection in about 15% to 50% of cases.
Patient, pre-cannulation disease factors heighten mortality risk in COVID-19 ECMO patients
A higher likely risk for mortality in COVID-19 patients receiving extracorporeal membrane oxygenation was found in older patients, men and those with chronic lung disease, according to study results published in Lancet Respiratory Medicine.
Anxiety, depression symptoms persist at 1 year among COVID-19 ECMO survivors
Patients treated with extracorporeal membrane oxygenation for COVID-19 acute respiratory disease had poorer physical and mental health 1 year later, according to study results.
Researchers identify transfusion threshold that confers lower mortality risk in VV ECMO
Packed red blood cell transfusion improved survival among adults with acute respiratory distress syndrome on venovenous extracorporeal membrane oxygenation when using a hemoglobin threshold of less than 7 g/dL, according to study results.
Scientific statement suggests more consideration for surgery in high-risk patients with PE
Evidence suggests that high-risk patients with pulmonary embolism can benefit from surgical management, according to a scientific statement issued by the American Heart Association.
Researchers identify clinical variable that predicts ability to wean from ECMO
A high effort to eliminate carbon dioxide was linked to a greater likelihood of failing to wean from venovenous extracorporeal membrane oxygenation, according to study results.
Increased risk for new mental health diagnoses found in ECMO survivors
Patients who survived after receiving extracorporeal membrane oxygenation were found to be at a higher risk for a new mental health diagnosis or social problem diagnosis than other ICU survivors, according to a study published in JAMA.
VIDEO: Takeaways from AHA 2022 with B. Hadley Wilson, MD, FACC
CHICAGO — In this Healio exclusive, B. Hadley Wilson, MD, FACC, provides his perspective on several late-breaking clinical trials presented at the American Heart Association Scientific Sessions.
Early ECMO does not improve outcomes vs. conservative strategy in cardiogenic shock
CHICAGO — Early veno-arterial extracorporeal membrane oxygenation for cardiogenic shock did not improve outcomes vs. a conservative strategy allowing for downstream extracorporeal membrane oxygenation in case of further hemodynamic decline, a speaker reported.
VIDEO: Takeaways from CHEST 2022 with Parth Rali, MD
NASHVILLE, Tenn. — In this Healio exclusive, Parth Rali, MD, spotlights education on mechanical circulatory support devices at the CHEST Annual Meeting.